Long-Term Effects of In Vivo Administration of An Anti-VLA-4 Antibody (natalizumab) on Mobilization of Committed and Primitive Hematopoietic Progenitor Cells In Humans.

Authors
Publication date
19 November 2010
Publisher
'American Society of Hematology'

Abstract

International audienc

    Similar works

    Full text

    thumbnail-image

    Available Versions

    HAL Université de Tours

    redirect
    oaioai:HAL:hal-00617184v1
    Last time updated on 12/11/2016